|
1
|
Yellon DM and Hausenloy DJ: Myocardial
reperfusion injury. N Engl J Med. 357:1121–1135. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Morgan EN, Boyle EM Jr, Yun W,
Griscavage-Ennis JM, Farr AL, Canty TG Jr, Pohlman TH and Verrier
ED: An essential role for NF-kappaB in the cardioadaptive response
to ischemia. Ann Thorac Surg. 68:377–382. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Liu P, Xu B, Cavalieri TA and Hock CE:
Attenuation of antioxidative capacity enhances reperfusion injury
in aged rat myocardium after MI/R. Am J Physiol Heart Circ Physiol.
287:H2719–H2727. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Sam F, Sawyer DB, Chang DL, Eberli FR,
Ngoy S, Jain M, Amin J, Apstein CS and Colucci WS: Progressive left
ventricular remodeling and apoptosis late after myocardial
infarction in mouse heart. Am J Physiol Heart Circ Physiol.
279:H422–H428. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Heusch G: Cardioprotection: Chances and
challenges of its translation to the clinic. Lancet. 381:166–175.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Jin G, Yang P, Gong Y, Fan X, Tang J and
Lin J: Effects of puerarin on expression of apelin and its receptor
of 2K1C renal hypertension rats. Zhongguo Zhong Yao Za Zhi.
34:3263–3267. 2009.(In Chinese). PubMed/NCBI
|
|
7
|
Ferdinandy P, Schulz R and Baxter GF:
Interaction of cardiovascular risk factors with myocardial
ischemia/reperfusion injury, preconditioning, and postconditioning.
Pharmacol Rev. 59:418–458. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Houshmand F, Faghihi M and Zahediasl S:
Biphasic protective effect of oxytocin on cardiac
ischemia/reperfusion injury in anaesthetized rats. Peptides.
30:2301–2308. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Sun B, Fan H, Honda T, Fujimaki R,
Lafond-Walker A, Masui Y, Lowenstein CJ and Becker LC: Activation
of NF kappa B and expression of ICAM-1 in ischemic-reperfused
canine myocardium. J Mol Cell Cardiol. 33:109–119. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ross SD, Kron IL, Gangemi JJ, Shockey KS,
Stoler M, Kern JA, Tribble CG and Laubach VE: Attenuation of lung
reperfusion injury after transplantation using an inhibitor of
nuclear factor-kappaB. Am J Physiol Lung Cell Mol Physiol.
279:L528–L536. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Nader ND, Li CM, Khadra WZ, Reedy R and
Panos AL: Anesthetic myocardial protection with sevoflurane. J
Cardiothorac Vasc Anesth. 18:269–274. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Brull DJ, Sanders J, Rumley A, Lowe GD,
Humphries SE and Montgomery HE: Impact of angiotensin converting
enzyme inhibition on post-coronary artery bypass interleukin 6
release. Heart. 87:252–255. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ishibashi T, Kijima M, Yokoyama K, Shindo
J, Nagata K, Hirosaka A, Techigawara M, Abe Y, Sato E, Yamaguchi N,
et al: Expression of cytokine adhesion molecule mRNA in atherectomy
specimens from patients with coronary artery disease. Jpn Circ J.
63:249–254. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Frangogiannis NG: Chemokines in ischemia
and reperfusion. Thromb Haemost. 97:738–747. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Takahashi T, Hato F, Yamane T, Fukumasu H,
Suzuki K, Ogita S, Nishizawa Y and Kitagawa S: Activation of human
neutrophil by cytokine-activated endothelial cells. Circ Res.
88:422–429. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wan IY, Arifi AA, Wan S, Yip JH, Sihoe AD,
Thung KH, Wong EM and Yim AP: Beating heart revascularization with
or without cardiopulmonary bypass: Evaluation of inflammatory
response in a prospective randomized study. J Thorac Cardiovasc
Surg. 127:1624–1631. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Tapuria N, Kumar Y, Habib MM, Abu Amara M,
Seifalian AM and Davidson BR: Remote ischemic preconditioning: A
novel protective method from ischemia reperfusion injury - a
review. J Surg Res. 150:304–330. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hausenloy DJ and Yellon DM:
Preconditioning and postconditioning: United at reperfusion.
Pharmacol Ther. 116:173–191. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Bai QH, Li WM, Liu HT, Chen WJ, Wang Y and
Yu C: Puerarin antagonizes activation effect of LPS on N9 microglia
cells. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 26:227–230. 2010.(In
Chinese). PubMed/NCBI
|
|
20
|
Zhu LH, Wang L, Wang D, Jiang H, Tang QZ,
Yan L, Bian ZY, Wang XA and Li H: Puerarin attenuates high-glucose-
and diabetes-induced vascular smooth muscle cell proliferation by
blocking PKCbeta2/Rac1-dependent signaling. Free Radic Biol Med.
48:471–482. 2010. View Article : Google Scholar : PubMed/NCBI
|
